Stocks
Celldex Therapeutics, Inc.CLDX
NASDAQHealthcareBiotechnology$30.90
A clinical-stage biotechnology company focused on developing monoclonal antibody therapies for inflammatory, allergic, and other immune-mediated diseases. Its pipeline includes investigational treatments targeting mast cell–driven disorders, with lead candidates advancing through mid- to late-stage ...
52W Range: $14.40 – $31.99
Congressional Interest in Celldex Therapeutics, Inc. (CLDX)
No congressional trades have been disclosed for Celldex Therapeutics, Inc. (CLDX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading CLDX?
No congressional trades found for this stock.